2nd EDITION

2015
 Community Pharmacy Benchmarking Guideline 2015

FOREWORD

The Ministry of Health's Vision: “A Nation Working Together for Better Health"
regards all stakeholders as partners in fulfilling its commitment towards
improving the health status of the population and providing access to quality
healthcare. Community pharmacists play major roles in reaching out to the
population as they are among the healthcare professionals who are most
accessible to the community. Besides, the standard and practice in the
community pharmacies reflects the pharmacy profession as a whole.
This benchmarking guideline serves as a set of standards that needs to be
complied with for the purpose of community pharmacy practice set up, training
activities (under-graduate / pre-registration), audits and complementing the
licensing requirement. The facilities should project a professional image befitting
the roles of community pharmacists without compromising the occupational and
safety requirements.
A checklist on benchmarking audit of community pharmacies is also included in
this edition to allow community pharmacies to conduct self-audits in order to
ensure adherence to proper practice and requirements. The criteria for general
pharmacy and pharmacy in a facility are also highlighted under zoning.
I would like to extend my heartfelt appreciation to everyone involved for their
tremendous support and invaluable contributions towards developing this
guideline. It is also my fervent hope that this guideline will serve its purpose well
in meeting our challenge to provide quality healthcare to the public.
Thank you.

DATO’ EISAH A. RAHMAN

Senior Director of Pharmaceutical Services
Ministry of Health Malaysia
 Community Pharmacy Benchmarking Guideline 2015

ACKNOWLEDGEMENTS

Editorial Committee

Azman Yahya
Pharmacy Board Malaysia
Ministry of Health

Fuziah Abdul Rashid

Pharmacy Board Malaysia
Ministry of Health

Salwati Abd Kadir

Pharmacy Board Malaysia
Ministry of Health

Hanisah Shafie
Pharmacy Board Malaysia
Ministry of Health

Contributors

Dr. Salmah Bahri

Pharmacy Practice and Development Division
Ministry of Health

Hj. Mohd Zulkifli Abdul Latif

Pharmacy Enforcement Division
Ministry of Health

Dr. Nour Hanah Othman

Pharmacy Policy and Management Division
Ministry of Health

Anis Talib
Pharmacy Practice and Development Division
Ministry of Health
 Community Pharmacy Benchmarking Guideline 2015

Salbiah Mohd. Salleh

Pharmacy Practice and Development Division
Ministry of Health

Rosminah Md. Din

Pharmacy Practice and Development Division
Ministry of Health

Fatimah Abdul Rahim

Pharmacy Practice and Development Division
Ministry of Health

Datin Dr. Faridah Aryani Md. Yusof

Pharmacy Practice and Development Division
Ministry of Health

Saimah Mat Noor

Pharmacy Practice and Development Division
Ministry of Health

Wan Mohaina Wan Mohammad

Pharmacy Practice and Development Division
Ministry of Health

Noraini Mohamad
Pharmacy Practice and Development Division
Ministry of Health

Fatkhiah Khalil
Pharmacy Practice and Development Division
Ministry of Health

Ainul Salhani Abdul Rahman

Pharmacy Practice and Development Division
Ministry of Health

Rosliza Lajis
Pharmacy Practice and Development Division
Ministry of Health
 Community Pharmacy Benchmarking Guideline 2015

Nur Sufiza Ahmad

Pharmacy Practice and Development Division
Ministry of Health

Nurul Adha Othman

Pharmacy Practice and Development Division
Ministry of Health

Wan Utma Sapini Wan Abdul Samad

Pharmacy Practice and Development Division
Ministry of Health

Phuar Hsiao Ling

Pharmacy Practice and Development Division
Ministry of Health

Hammira Abdul Razak

Pharmacy Practice and Development Division
Ministry of Health

Datcayani a/p Ramadoo @ Devudu

Pharmacy Board Malaysia
Ministry of Health

Rosilawati Ahmad
National Pharmaceutical Control Bureau
Ministry of Health

Nurul Fajar Mohd Jamid

National Pharmaceutical Control Bureau
Ministry of Health

Azlina Ismail
National Pharmaceutical Control Bureau
Ministry of Health

Adnan Salimin
Kuala Lumpur Pharmacy Enforcement Division
Ministry of Health
 Community Pharmacy Benchmarking Guideline 2015

Asniza Alias
Kuala Lumpur Pharmacy Enforcement Division
Ministry of Health

Hariah Mohd Derus

Selangor Pharmacy Enforcement Division
Ministry of Health

Siti Mariaton Abd Moksin

Selangor Pharmacy Enforcement Division
Ministry of Health

Amrahi Buang
University Malaya Medical Centre

Prof. Dr. Mohamed Azmi Ahmad Hassali

School of Pharmaceutical Sciences
Universiti Sains Malaysia

Andrew Tan
Malaysian Pharmaceutical Society (MPS)

Datin Mariani Ahmad Nizaruddin

Malaysian Pharmaceutical Society (MPS)

Keh Song Hock

Malaysian Pharmaceutical Society (MPS)

Wan Hwei Yen

Malaysian Pharmaceutical Society (MPS)

Wong Sie Sing

Malaysian Community Pharmacy Guild (MCPG)

Lovy Beh
Malaysian Community Pharmacy Guild (MCPG)

Loh Peng Yeow

Malaysian Community Pharmacy Guild (MCPG)
 Community Pharmacy Benchmarking Guideline 2015

Hj. Abdul Rahman Lim Abdullah

Malaysian Community Pharmacy Guild (MCPG)

Chin Kim Lin

Malaysian Community Pharmacy Guild (MCPG)

Ewe Kheng Huat

Pharmaceutical Association of Malaysia (PhAMA)

Cheah Ming Loong

Malaysian Organisation of Pharmaceutical Industries (MOPI)

Sabrina Haron
Malaysian Organisation of Pharmaceutical Industries (MOPI)

Lim Teng Chyuan

Malaysian Association of Pharmaceutical Suppliers (MAPS)

Dr. Choe Tong Seng

Malaysian Association of Pharmaceutical Suppliers (MAPS)
 Community Pharmacy Benchmarking Guideline 2015

TABLE OF CONTENTS

1.0 INTRODUCTION ..........................................................................................10

2.0 OWNERSHIP................................................................................................10
3.0 PREMISES ...................................................................................................10
3.1 Location...................................................................................................10
3.2 Medicine Dispensing Area (MDA)...........................................................11
3.3 Signboard & Advertisement ...................................................................12
3.4 Facilities ..................................................................................................12
3.5 Occupational and safety requirements: .................................................15
3.6 References ..............................................................................................16
4.0 PRACTICE ...................................................................................................16
4.1 Service.....................................................................................................16
4.2 Type of products .....................................................................................16
4.2 Personnel ................................................................................................17
4.3 Storage of medicines ..............................................................................17
4.4 Safetyand Quality Improvement Activities.............................................18
4.5 Record .....................................................................................................19
4.6 Operating Hours......................................................................................19
5.0 STANDARD OPERATING PROCEDURE .........................................................19
5.1 Counseling and Dispensing Medicines ...................................................19
5.2 Response to Minor Health Problems/ Sales of Pharmacy Medicines
(Self-care)...........................................................................................................19
5.3 Self-monitoring Devices..........................................................................21
5.4 Health Screening.....................................................................................21
5.5 Extemporaneous Dispensing ..................................................................22
5.6 Awareness of Original and Counterfeit drugs, OTC and herbal
supplements ......................................................................................................23
6.0 OPTIONAL PROFESSIONAL SERVICES..........................................................23
6.1 Patient Medication Review (PM Review) ...............................................23
 Community Pharmacy Benchmarking Guideline 2015

6.2 Health Promotion ...................................................................................26

Appendix I..............................................................................................................28
Appendix II.............................................................................................................29
Appendix III............................................................................................................30
Appendix IV............................................................................................................31
AppendixV .............................................................................................................32
AppendixVI ............................................................................................................33
 Community Pharmacy Benchmarking Guideline 2015

COMMUNITY PHARMACY BENCHMARKING GUIDELINE

1.0 INTRODUCTION

This benchmarking guideline serves as a set of standards that needs to be

complied with for the purpose of community pharmacy practice set up,
training activities (under-graduate / pre-registration), audits and
complementing the licensing requirement.

The purpose of this guideline is to ensure the quality of the community

pharmacy practice for the benefit of consumer/ patients.

For the purpose of this guideline, the community pharmacy is defined as a

premise with at least one pharmacist holding a Type A license issued under
the Poisons Act 1952 who can supply/sell poison either by retail only or by
both retail and wholesale.

2.0 OWNERSHIP

A community pharmacy should be legally incorporated, complying with

current government policy and relevant legislations.

The community pharmacist should:

 have full management control of the pharmacy practice
 have significant representation in executive board and possess share
equity
 inform any changes in shareholding to the Licensing Officer and/or any
other relevant authorities

3.0 PREMISES

3.1 Location

The premises are located within the management of the Local Council,
where appropriate.

Pharmacies need to comply with the Local Authority laws.

10 |
 Community Pharmacy Benchmarking Guideline 2015

The pharmacy premise cannot be shared with any other businesses

(including Multi-Level Marketing business)

Under certain circumstances where sharing of premise is unavoidable, the

following conditions must be complied with:
 Full separation with no access allowed between the different businesses
in the same premises
 Should have different access points and clear signages
 Different business entities
 Each premise has its own staff

For a pharmacy in a shop lot:

 A new pharmacy should be located at least 300 meter radius from an
existing pharmacy outlet.

For a pharmacy within a facility/shopping complex/ business center/ multi-

storey building:
 1 outlet for every 200,000 square feet rentable space and below

A new pharmacy should be located at least 150meters in a linear

measurement distance (shortest legal travelling route) to the main entrance
of the facility from nearest pharmacy.

(Please refer to Appendix I)

3.2 Medicine Dispensing Area (MDA)

The MDA should:

 be a minimum of 18 square meter (193 sq. ft)
 consist of :
 Prescription counter
 Counseling area
 Medicines preparation area (dry and wet compounding)
 Screening tests area

11 |
 Community Pharmacy Benchmarking Guideline 2015

3.3 Signboard & Advertisement

Pharmacy signboard must project the professional image of a pharmacy.

No advertisement is permitted in any pharmacy signboard. This applies to

signboards of both existing and new pharmacy businesses.

Any posters or products advertisements displayed to public must be in

accordance with the relevant legislations/guidelines.

The types of services offered should be displayed clearly inside the

premises.

Examples of services are:

 Blood Glucose Test
 Certified Smoking Cessation Service Provider Program (CSCSP)
 Urine Pregnancy Test
 Electronic blood pressure monitoring
(Other service(s) displayed is subjected to the relevant legislations)

Notice of the pharmacist(s) on duty to be displayed must include:

 Name of pharmacist(s)
 Time and date/day of duty
 Photo (optional)

Certificates of Registration and Annual Retention for the pharmacist in-

charge should also be displayed clearly.

“No Smoking” signs must be displayed prominently to promote healthy

lifestyle.

Designated areas are indicated clearly, such as “Prescription Counter” or

“Pharmacy”.

3.4 Facilities

Drugs and merchandises should be displayed in a neat and tidy manner thus
projecting a professional image.

12 |
 Community Pharmacy Benchmarking Guideline 2015

Pharmacist office (optional).

Medicine Dispensing Area/ Prescription Counter

 Preferably without any barrier to facilitate patient counseling and for
more effective communication.
 Enable safe and efficient workflow.
 Pharmacist should be able to maintain a direct supervision of the
pharmacy and staff from this area.
 Size and organization of this area should be adequate for the volume of
work.

Counseling area must be a properly designated area, private and

comfortable.
 If it is a room, the door should be made of half glass

Waiting area
 Comfortable with adequate space for customers.

Lighting and ventilation

 Ensure adequate lighting to reduce risk of medication errors.
 Bright white fluorescent lights are preferred to filament.

Noise level
 Acceptable noise level - may have soft background music.

Air-conditioner with scheduled maintenance to ensure the stability of

medicines and for the comfort of staff and customers.

Refrigerator
 Should be maintained at temperature between 2 – 8oC.
 Daily temperature reading must be recorded and verified.
 Appropriate action should be taken to rectify any problems identified.
 Do not store food or drinks in the refrigerator used for the storage of
medicines.

Cleanliness
 There should be appropriate pest control measure.
 Daily cleaning to maintain the pharmacy in a tidy and dust free state.
 Regular cleaning of merchandise.

13 |
 Community Pharmacy Benchmarking Guideline 2015

 Written cleaning procedures and schedules should be set out and made
available.

Medicines Preparation Area

 A washbasin with water supply should be available, other than in the
toilet.

a) “Wet Compounding Area”

(for the purpose of extemporaneous preparations only)
 A designated area with sink and water supply.
 Should be away from food and drinks.
 All working surfaces and shelves should have a smooth impervious
surface and washable material finishing.
 Wet compounding area must be equipped with the following, if
applicable:
i. Weighing scale
- Regular verification and calibration by relevant bodies are
required to ensure reliability and efficiency
ii. Mortar and pestle
- Must be maintained in good condition.
iii. Tile/glass slabs with spatula
- Must be maintained in good condition.
iv. Measuring appliances
- Must be maintained in good condition.

b) “Dry Compounding Area”

 A designated area for counting tablets/ capsules, filling and packing of
medicines. Also for labeling the prepared medicines.
 Should be away from food and drinks.
 Provide suitable and hygienic means of counting tablets/capsules (e.g.
counting tray).

Health Screening Area

 Equipped with appropriate equipment and devices.
 Equipment and devices in reliable conditions at all times.
Water closet (optional)

14 |
 Community Pharmacy Benchmarking Guideline 2015

Equipment

a) Computerized system (where available) preferably with the following

functions:
 Pharmacy Information Software
 Inventory/Stock keeping
 Printing of labels
 Printing of customer information leaflet
 Keeping of patient medication record
 Itemised billing with GST function
 Appropriate drug naming system

b) Printer (where available) preferably with the following functions:

 For the production of labels, leaflets or any printed materials.

c) Cabinets
 For the storage of documents/ records.

d) Labels
 Appropriate sizes and shapes
 Preferably printed to prevent/ minimize errors due to illegible
handwriting

Other Requirements (optional)

 Entrance should be accessible to wheelchairs and pushchairs.
 Pantry area for staff.
 Adequate toilet facilities, clean and in good condition.
 Arrangement must be made for the regular collection and safe disposal
of pharmaceutical waste and other refuse.

3.5 Occupational and safety requirements:

The premises should be safe for the public and staff working in the
pharmacy. Must comply with all statutory requirements where appropriate:
 Appropriate fire escape way
 Fire alarm
 Fire extinguisher
 Occupier’s indemnity

15 |
 Community Pharmacy Benchmarking Guideline 2015

3.6 References
The following references should be available:
 British National Formulary or Australian Formulary
 Code of Conduct for Pharmacist and Bodies Corporate
 All relevant pharmacy legislations.

Optional:
 Martindale
 MIMS
 References for herbal medicines

4.0 PRACTICE

4.1 Service

Essential services
 Screening of prescription(s)
 Dispensing of medicines
 Compounding of medicines (patient specific)
 Counseling and advisory
 Monitoring and screening tests
 Pharmacy management in drug procurement
 Proper documentation

Optional Services
Medication review and accredited pharmacy services including:
 Home Medication Review (HMR)
 Medication Therapy Adherence Clinic (MTAC)
 Certified Smoking Cessation Service Provider (CSCSP)
 Weight management
 Health screening
 Any other certified pharmaceutical care services

4.2 Type of products

70% of the merchandise in a community pharmacy should consist of

registered pharmaceutical products, health and nutritional products,
surgical and medical devices, personal care and rehabilitation aids.

16 |
 Community Pharmacy Benchmarking Guideline 2015

Sale of goods and food which is harmful to health is strictly prohibited. Non-
pharmacy products, e.g gift items, cards and drinks, should be minimized.

4.2 Personnel

a) Pharmacists
 Registered with the Pharmacy Board of Malaysia
 Observe the Code of Conduct for Pharmacists and Bodies Corporate
 Comply with all the pharmacy legislations of Malaysia
 Dress code
i. Pharmacist Tunic (White Coat)
ii. Must project a professional image
 Name tag must have the word “Pharmacist”
 Ratio of pharmacist to prescription should not exceed 80 to 100
prescriptions per pharmacist per day
 Notice and photograph of the pharmacist on duty must be displayed
with the duty hours
 The pharmacist in a new community pharmacy has to possess at least 4
years working experience as a pharmacist or 2 years as a community
pharmacist

b) Pharmacy Assistants
 Diploma in Pharmacy are preferred
 Structured training
 Suitable number

 The role of the pharmacy assistants are to help in the preparation of

medicines to be dispensed. They are not allowed to dispense scheduled
poisons without a pharmacist.

4.3 Storage of medicines

All medicines must comply with labeling requirements and should be kept in
the original packaging or properly labeled containers.

Different categories of items should be systematically arranged.

17 |
 Community Pharmacy Benchmarking Guideline 2015

Separate storage should be provided for internal and external medicines.

Medicines with similar names and packaging should be distinctively
separated to prevent dispensing errors.
All scheduled poisons under the Poisons Act 1952 must be stored in
accordance with the legislations.

Poison B and Poison C items as listed in Part I of the Poison List should be
kept in a locked cabinet to prevent access to customers and unauthorised
personnel.

Psychotropic drugs/ dangerous drugs must be kept according to Regulations

24, Poison (Psychotropic Substances) Regulations 1989 whereas Dangerous
Drugs should be kept according to Regulations 9(2) Dangerous Drugs
Regulations 1952. A separate, safe and locked cabinet should be used for
storage of psychotropic substances and dangerous drugs away from other
goods/medicines.

All keys must be kept by the pharmacist.

Storage conditions must comply with manufacturer instructions and cold

chain requirements where relevant.

4.4 Safety and Quality Improvement Activities

Secure locks on main door and grille/gate.

Secure locks on back doors and grille/gate if applicable.

Electronically controlled locks may be utilised.

Additional safety control such as video cameras and alarm system are
advisable.

Policy for appropriate security should be arranged.

To comply with relevant statutory requirements.

To comply with Good Dispensing Practice. (Please refer to GDsP Guideline)

18 |
 Community Pharmacy Benchmarking Guideline 2015

4.5 Record

Records and documentations should be kept and updated systematically as

stipulated by the law.

4.6 Operating Hours

Minimum 40 hours/week with pharmacist

5.0 STANDARD OPERATING PROCEDURE

5.1 Counseling and Dispensing Medicines

Refer to GDsP Guidelines

5.2 Response to Minor Health Problems/ Sales of Pharmacy Medicines (Self-

care)

This SOP applies to situations where the customer/patient comes to the

pharmacy to consult the pharmacist on a minor health problem or request
to purchase a pharmacy medicine or an over-the-counter medicine by
name.

All pharmacy staff must be adequately trained. They should also know when
to refer the customer to the pharmacist.
Pharmacists and their staff must be aware of the potential of misuse for
certain non-prescription medicines and should not supply when there are
reasonable grounds for suspecting misuse/wrongful use.

Pharmacy should have an area for confidential conversation with the

patient/customer.

19 |
 Community Pharmacy Benchmarking Guideline 2015

Pharmacists should counsel/ assess the health problem after obtaining

sufficient information on the following:
 Who has the problem: if a child, the age of the child is required
 What are the problems
 How long has the condition existed
 Action already taken
 Medicines already used for the problem
 Medical history: allergies, other existing health problems and
medication history
 To rule out possible underlying serious acute diseases
 When to refer to a medical practitioner or other health
professionals, with a referral note(refer to Appendix iv).

After the assessment, the pharmacist should:

 Differentiate minor ailments from major diseases
 Minimize risk factors and complications
 Offer appropriate advice (non-pharmacological and/or
pharmacological)
 Counsel patient/customer on the efficacy and safety of
the medicine(s) recommended
 Refer patient/customer to a medical practitioner or other
Health care professionals when appropriate.

When counseling patient:

 Make sure the patient knows/understands the objective of the
treatment.
 Go through the treatment as to why, what, when and how to use
The medicine(s).
 Advise on non-pharmacological treatment when appropriate.
 Advise on possible side-effects and contraindications.
 If symptoms persist, the patient should be advised to see a
Medical practitioner with a referral note.

Documentation

Proper documentation should be maintained to fulfill legal and professional

requirements.

20 |
 Community Pharmacy Benchmarking Guideline 2015

Preferably, the pharmacy should maintain patient medication record:

 To check the progress of the treatment and provide information
on the medical history of the patient.
 To be kept in pharmacy computer systems or in manual records.
 Should be pertinent, accurate, up-to-date, stored securely and
treated as confidential and used only for the purpose for which it
is obtained.

Labeling

Refer to Guide to Good Dispensing Practice

5.3 Self-monitoring Devices

Pharmacist should give full information to the patients on the use of the
self-monitoring devices and the frequency of measurement.

Patients may be asked to perform self-monitoring under the guidance of the

pharmacist to ensure effective learning of the technique.

Encourage patients to document their own results. Help them to

understand the results.

5.4 Health Screening

All staff involved in providing the above service should be trained in the use
of the monitoring devices and the procedures. They should also be aware of
the limits of the tests provided.

The pharmacy must have a suitable area with facilities to perform the tests
and provide counseling.

Ensure that the devices used are in good order.

Keep up to date with the latest development and know when to refer
patients to medical practitioners.

Before conducting the test, explain the procedure to the patient.

21 |
 Community Pharmacy Benchmarking Guideline 2015

Communicate test results to the patient in a manner in which he/she can

understand and provide appropriate counseling.

5.5 Extemporaneous Dispensing

Ensure that the formula and intended method of preparation is correct.

Requisite facilities and equipment for the preparation are available and
maintained in good order.

Ingredients must be sourced from reliable pharmaceutical supplier and be

of a quality accepted for use in the preparation of the extemporaneous
products.

All calculations, ingredients and quantities should be checked by a second

person who is a pharmacist.

Pharmacists must pay particular attention to substances that may be

hazardous and require special handling techniques.

The product must be suitably labeled with the necessary information,

including special requirements for the safe handling and storage of the
product including an expiry date.

Document the preparation and keep the records for at least 2 years. The
records must include the formula, the ingredients and the quantities used,
their source, batch number, expiry date, date of preparation and personnel
involved in the preparation.

All documentations should be certified and duly stamped by a registered

pharmacist with his/her registration number indicated.

Labeling

Refer to Guide to Good Dispensing Practice

22 |
 Community Pharmacy Benchmarking Guideline 2015

5.6 Awareness of Original and Counterfeit drugs, OTC and herbal supplements

Pharmacist should only buy medicines from legitimate sources

Pharmacies must be equipped with the Meditag reader in order to ascertain

if a product is genuine and registered with the competent authority.

Pharmacists must educate customers on how to identify counterfeit

medicines.

Pharmacists must be able to check the registration of a product through the

National Pharmaceutical Control Bureau (NPCB) website.

Pharmacists must be aware of the latest information on de-registered

products, products found containing adulterated ingredients, changes to
product information and safety issues.

6.0 OPTIONAL PROFESSIONAL SERVICES

6.1 Patient Medication Review (PM Review)

Patient Selection

Patient selection must have the following criteria:

 A PM Review can be conducted with patients on multiple medications
and those with long-term conditions.
 These regular PM Reviews, initiated by the pharmacist, shall only be
provided for patients who have been patronizing the pharmacy for the
dispensing of prescriptions for at least the past three months.
 PM Review can be conducted every 3 months after the last PM Review.
 Self-referral by patients.
 Referral by medical practitioners.
 Referral by other health care professionals, e.g. nurses, key workers
and social services.
 Identified by the pharmacist as having problems with medicine e.g.
poor compliance, problems with administration and complicated
medicine regimen.

23 |
 Community Pharmacy Benchmarking Guideline 2015

Appointment

Schedule the appointments for the PM Review to be carried out.

Give the patient an appointment card with the date and time.

Give patient an option for care giver to be present.

Inform the patient that the appointment will last for about 30 minutes.

Inform the patient to bring their medicines including any complementary

medicines, vitamins or any medicines they are taking regularly.

A day before the review, remind the patient about his/her appointment.

Review

Prior to the review:

 Prepare the pharmaceutical care plan.
 The pharmacist should be fully aware of the appropriate
use/ dose/ administration time/ side effects and major drug interactions
of each medicine the patient is taking.
 The pharmacist may need to refer to treatment guidelines as needed.

During the review:

 Welcome patient and make the patient comfortable in the

consultation area.
 Explain the aims of the review.
 Explain the patient’s consent.
 Explain that the information will be shared with their GP and a record
will be kept in the pharmacy.
 Confirm and complete patient details on a PM Review form (refer
Appendix iv).
 Record the basic health data section of the form.
 For each medicine the pharmacist should consider the following
interventions:
i. Advice on medicines usage (prescribed and OTC), aiming to
develop compliance;

24 |
 Community Pharmacy Benchmarking Guideline 2015

ii. Effective use of ‘when required’ medicines;

iii. Ensuring appropriate use of different medicine dosage forms
(e.g. inhaler and soluble tablets);
iv. Advice on possible side effects;
v. Identification of items without adequate or correct dosage
instructions;
vi. Identification of unwanted medicines (if patient is no longer
taking their medicines);
vii. Identification of the need for a change of dosage form to
facilitate effective usage;
viii. Suggestions of appropriate substitutes, if required;
ix. Proposals for dose optimization;
x. Suggestions to improve patient’s clinical outcome;
xi. Advice on the use of any vitamins, complementary medicines
or self purchased OTC medicines.

During the review, other health-related issues should be discussed such as:
 Practical problems in ordering, and obtaining their medicines.
 General problems in taking and using medicines, e.g. compliance
charts.
 Health promotion advice where appropriate.
 Referral to other health care providers.

Complete the action plan

 The action plan will probably contain no more than 4 key points.
 Discuss the action plan with the patient and get patient’s consent
 Discuss with the patient information that requires follow-up.

The PM review form shall be completed and a copy will be given to the
patient at the end of the review.

Thank the patient and see him/her out.

Post review:
 Send a copy of the review form to the patient’s GP
 Update the patient medication record.
 File all documents systematically and securely.
 Follow up on any actions you have agreed to do with the patient.
 Record number of PM Reviews performed.

25 |
 Community Pharmacy Benchmarking Guideline 2015

6.2 Health Promotion

Health promotion is the process of enabling people to have increased

control over, and to improve their health. Community pharmacists can play
a very important role in promoting, maintaining and improving the health of
communities that they serve.

6.2.1 Smoking Cessation

 Before providing this service, the pharmacists should have undergone

the Certified Smoking Cessation Service Provider Program (CSCSP).
 Pharmacists should apply the 5 A’s in the screening and assessment
of customers:

Ask : Pharmacists should systematically identify all

tobacco users among the customers who visit the
pharmacy.
Advise : Pharmacists should strongly urge all tobacco users
to quit.
Assess : Pharmacists must determine the willingness of the
customers to make the quit attempt.
Assist : If the customer is willing to quit, the pharmacist
must help to devise an effective quit plan – provide
practical counseling and recommend the use of
approved pharmacotherapy.
Arrange : Pharmacists must also devise a follow-up plan to
ensure the success of the quitting process.

 For customers who have no intention to quit smoking, pharmacists

should advice them of the possible health hazards of smoking.
Pharmacists should provide them with leaflets and materials that they
can take home to read. Customers should be assured of the
pharmacist’s readiness to help them quit smoking.

 If the customer is an ex-smoker (has not smoked for 6 months), the

pharmacist should advise the customer on the dangers of relapse and
offer solutions to overcome any potential problems.

26 |
 Community Pharmacy Benchmarking Guideline 2015

 If the patient is an ex-smoker (has not smoked for 12 months), the

pharmacist should reinforce the benefits of cessation and help the
customer to maintain smoke free.

 Pharmacists should document the service provided and keep a record of

the follow-ups for the individual customer in a prepared format to
enable the service to be audited.

6.2.2 Weight Management

 Pharmacists intending to provide a weight management program should

have a good understanding about obesity and the multi-disciplinary
approach to weight management, which includes dieting, exercise,
behavior modifications and recommendation of approved and suitable
pharmacotherapy and/or evidence-based natural therapies.

 Pharmacists and staff should offer to do a Body Mass Index (BMI)

screening and a waist circumference measurement on potential
customers.

 If a more sophisticated weighing apparatus is available, measurements

of total body fats, visceral fats and muscle mass would be more useful.

 Pharmacists and staff should be able to interpret the results and explain
the risks involved if one is overweight or obese.

 Pharmacists should be able to recommend a weight reduction program

suitable for the customer and design the proper follow-up visits in order
to monitor the customer’s progress.

 Customers who are overweight/ obese and who also have other co-
morbidities such as diabetes, hypertension, hyperlipidemia, fatty liver,
arthritis and gout should be encouraged to lose at least 5 to 10% of their
body weight in order to reduce the risks associated with their weight.
These customers may have to be referred to a physician if the need
arises.

27 |
 Community Pharmacy Benchmarking Guideline 2015

Appendix I

ZONING
Establishing a new pharmacy

A. For general pharmacy

Criteria:
1. National Population ratio : 1 pharmacy outlet in 5,000 population  5,800
outlets
2. District ratio 1 in 5,000 (urban) and 1 in 10,000 (rural)
*urban & rural as defined in National Population Census
3. Distance from nearest pharmacy 300 meters in a linear measurement
(shortest legal travelling route)  official surveyor’s report must be
submitted if the distance is very close to the 300 meters limit (measuring
from the centre of the main entrance of the proposed premise to the centre
of the main entrance of the nearest existing pharmacy)
4. As near to existing clinics as possible

B. For pharmacy in a facility

1. District ratio 1 in 5,000 (urban) and 1 in 10,000 (rural)

*urban & rural as defined in National Population Census
2. 1 outlet for every 200,000 square feet rentable space and below
3. Distance from nearest general pharmacy 150 meters in a linear
measurement (shortest legal travelling route) to the main entrance of the
facility

Number of outlets allowed in facility

Distance between general pharmacy ≤ 150 meters ≥ 150 meters

& facility / complex
Rentable retail space
≤ 200,000 square feet 0 1
200,000 – 400,000 square feet 1 2
400,000 – 600,000 square feet 2 3

28 |
 Community Pharmacy Benchmarking Guideline 2015

Appendix II

EXAMPLE OF SKETCH-PLAN FOR COMMUNITY PHARMACY (TYPE A)

*DOOR

*WATER CLOSET
BACK

DISPENSING ROOM/
POISON STORE
GENERAL
STORE
(NON-
POISON)
PHARMACIST
OFFICE/
COUNSELING
ROOM

*SLIDING DOOR

POISON
CABINET

PRESCRIPTION
/ DISPENSING
COUNTER

OTC CABINET

OTC SHELF/
CABINET
DISPLAY CABINET

ENTRANCE

Notes: 1. The sketch is not scale based.

2. The estimated width for each premise is according to appropriateness.
3. *Optional
This document is for guidance purpose and subjected to amendments.
29 |
 Community Pharmacy Benchmarking Guideline 2015

Appendix III
EXAMPLE OF SKETCH-PLAN FOR COMMUNITY PHARMACY (TYPE B)
BACK *WATER
CLOSET

DISPENSING ROOM/ POISON

STORE

POISON CABINET

PRESCRIPTION/ DISPENSING
COUNTER

SHELF/
CABINET

OTC CABINET OTC CABINET

ENTRANCE

Notes:
1. The sketch is not scale based.
2. The estimated width for each premise is according to appropriateness.
3. * Optional
This document is for guidance purpose and subjected to amendments.

30 |
 Community Pharmacy Benchmarking Guideline 2015

Appendix IV

TEMPLATE OF REFERRAL NOTE

FROM
Pharmacist :________________________________ Phone :_____________________
Address :________________________________ Fax :_____________________
__________________________________________ Email :_____________________

TO
Doctor :________________________________ Phone :_____________________
Address :________________________________ Fax :_____________________
__________________________________________ Email :_____________________

Name of patient :________________________________________________________

NRIC :______________________________
Phone :______________________________

The above named patient is being referred to you for the following:-

1) Presented with signs and symptoms which require further investigation by a

medical practitioner
2) Review of the patient’s medications
3) Management of drug related problem(s)

Please contact me if required, so that we can provide the best care possible to the
patient. Thank you.

Date:_______________________ Pharmacist’s signature and official stamp:

This document is for guidance purpose and subjected to amendments.

31 |
 Community Pharmacy Benchmarking Guideline 2015

Appendix V

TEMPLATE OF PATIENT MEDICATION REVIEW FORM

Patient Name : ___________________________________________________

File Number : ___________________________________________________

Date of Review : ___________________________________________________

NO. MEDICATION ACTUAL INDICATION MEDICATION PLAN OF OUTCOME

(including DOSE/ ISSUE ACTION
strength & FREQUENCY (e.g. none, (e.g.
frequency TAKEN BY duplication, reduce/increase
prescribed) PATIENT compliance, dose, cease
adverse medication,
events, counsel patient,
polypharmacy, etc.)
etc.)
1

4
This document is for guidance purpose and subjected to amendments.

32 | P a g e
 Community Pharmacy Benchmarking Guideline 2015

Appendix VI

Pharmacy Board of Malaysia

Ministry of Health Malaysia
Lot 36, JalanUniversiti,
46350, Petaling Jaya, Selangor

COMMUNITY PHARMACY BENCHMARKING

Community Pharmacy
Premise Name
Address
State
Contact Number Postal Code
Email Fax Number

Pharmacist Details
Name Type A License Number Validity

*Panel
Date Time
Chief Panel
Panel 1
Panel 2
Panel 3
*Minimum of 2 members

Signature _______________________ __________________________

Pharmacist on Duty Name

_______________________ Name __________________________

Chief Panel

33 | P a g e
 Community Pharmacy Benchmarking Guideline 2015

SECTION 1: COMPULSORY

34 | P a g e
 Community Pharmacy Benchmarking Guideline 2015

DESCRIPTION COMPLIANCE NOTES/COMMENTS

0 1
1. OWNERSHIP
Full management control of pharmacy practice by pharmacist.
TOTAL (1 mark)
2. PREMISES
Location (1 mark)
No sharing with other Business.
Medicine Dispensing Area (MDA) (3 marks)
MDA consists of:
 Prescription counter
 Counseling area
Should be clean and tidy
Signboard and Advertisement (5 marks)
Pharmacy signboard project the professional image of a pharmacy
Notice of the pharmacist(s) on duty is displayed which include:
 Name of pharmacist(s)
 Time and date/day of duty
Certificates of Registration and Annual Retention for the
pharmacist in-charge are clearly displayed.

35 | P a g e
 Community Pharmacy Benchmarking Guideline 2015

DESCRIPTION COMPLIANCE NOTES/COMMENTS

0 1
Designated areas are clearly indicated,
e.g “Prescription Counter” or “Pharmacy”.
Facilities (16 marks)
Medicine Dispensing Area/ Prescription Counter
 Without any barrier (to facilitate patient counseling and
for more effective communication).
 Enable safe and efficient workflow.
 Pharmacist is able to maintain a direct supervision of
the pharmacy and staff from this area.
 Size and organization of this area is adequate for the
volume of work
Counseling area is a properly designated area, private and
comfortable
Air-conditioner with scheduled maintenance
Refrigerator
 Temperature is maintained between 2 – 8oC.
 Records of temperature is available and verified
 Does not store food or drinks

36 | P a g e
 Community Pharmacy Benchmarking Guideline 2015

DESCRIPTION COMPLIANCE NOTES/COMMENTS

0 1
Cleanliness
 Appropriate pest control measure is made available.
Dry Compounding Area (Medicines Preparation / Filling Area)
 A designated area for counting tablets/ capsules, filling,
packing of medicines and for labeling the prepared
medicines.
 Located away from food and drinks.
 Provide suitable and hygienic means of counting
tablets/capsules (e.g. counting tray).
Equipment
a) Cabinets
 For the storage of documents/ records.
b) Labels
 Appropriate sizes and shapes
 Legible

Occupational and safety requirements (1 mark)

 Fire extinguisher

37 | P a g e
 Community Pharmacy Benchmarking Guideline 2015

DESCRIPTION COMPLIANCE NOTES/COMMENTS

0 1
References (2 marks)
 Drug Information Handbook/ British National Formulary
(or any other reliable references – hardcopy or online)
 Code of Conduct for Pharmacist and Bodies
Corporate (hardcopy or online)
TOTAL (27 marks)
3. PRACTICE AND SERVICES
Services (5 marks)
Essential Services
• screening prescriptions
 medicines dispensing
 dispensing instruction
• medication counseling
• pharmacy management in drug procurement and
documentation
Type of Products (2 marks)
 70% of the merchandise in a community pharmacy
consists of registered pharmaceutical products, health

38 | P a g e
 Community Pharmacy Benchmarking Guideline 2015

DESCRIPTION COMPLIANCE NOTES/COMMENTS

0 1
and nutritional products, surgical and medical devices,
personal care and rehabilitation aids.
 Sale of goods and food which is harmful to health is
strictly prohibited. Non-pharmacy products, e.g gift
items, cards and drinks, should be minimized.

Personnel (9 marks)
a) Pharmacists
 Registered with the Pharmacy Board of Malaysia
 Observe the Code of Conduct for Pharmacists and
Bodies Corporate
 Comply with all the pharmacy legislations of
Malaysia
 Dress code
i. Pharmacist Tunic (White Coat)
ii. Project a professional image
 Name tag with the word “Pharmacist”
 Suitable number of pharmacists

39 | P a g e
 Community Pharmacy Benchmarking Guideline 2015

DESCRIPTION COMPLIANCE NOTES/COMMENTS

0 1
i. in line with the workload of the pharmacy
ii. workload preferably should not exceed 150
prescriptions/pharmacist/day
 Minimum distraction when filling prescriptions
or carrying out pharmacy services
Storage and Security of Medicines (8 marks)
All medicines comply with labeling requirements and kept in the
original packaging or properly labeled containers.
Different categories of items are systematically arranged.
Separate storage is provided for internal and external medicines.
Medicines with similar names and packaging are distinctively
separated.
Poison B and Poison C items as listed in Part I of the Poison List are
kept in a locked cabinet.
All keys are kept by the pharmacist.
Storage conditions complied with manufacturer instructions and
cold chain requirements.
Secure locks on main door and grille/gate

40 | P a g e
 Community Pharmacy Benchmarking Guideline 2015

DESCRIPTION COMPLIANCE NOTES/COMMENTS

0 1

Medication Safety and Quality Improvement Activities (4 marks )

ADR reporting
ME reporting
Product Recall
Regular collection and safe disposal of pharmaceutical waste and
other refuse.
Record and Documentation (4 marks)
Records and documentations are kept and updated systematically
Necessary documentation are completed by pharmacy staff:
 Prescription details are entered into record
book(s)/computer.
 Patient medication record (PMR) are kept appropriately



Legal and professional requirements for record keeping and record
management are adhered to at all times – (confidentiality and

41 | P a g e
 Community Pharmacy Benchmarking Guideline 2015

DESCRIPTION COMPLIANCE NOTES/COMMENTS

0 1
security of patient data should are considered)
Operating Hours (1 mark)
 Minimum 40 hours/week with pharmacist
TOTAL (33 marks)
4. STANDARD OPERATING PROCEDURE
Handling Minor Ailments (4 marks)
 All pharmacy staffs are adequately trained and know
when to refer the customer to the pharmacist.
 Pharmacists and their staff are aware of the potential
of misuse for certain non-prescription medicines and
do not supply when there are reasonable grounds for
suspecting a misuse.
 Area for confidential conversation with the
patient/customer is available.
 Proper documentation is maintained to fulfill legal and
professional requirements.
Identification of Registered and Counterfeit Drugs (4 marks)
 Meditag reader is available.

42 | P a g e
 Community Pharmacy Benchmarking Guideline 2015

DESCRIPTION COMPLIANCE NOTES/COMMENTS

0 1
 Pharmacists educate customers on how to identify
counterfeit medicines.
 Pharmacists are able to check the registration of a
product through the competent authority.
 Pharmacists are aware of the latest information on de-
registered products, products found containing
adulterated ingredients, changes to product
information and safety issues.
TOTAL (8 marks)

43 | P a g e
 Community Pharmacy Benchmarking Guideline 2015

SECTION 2: OPTIONAL

44 | P a g e
 Community Pharmacy Benchmarking Guideline 2015

DESCRIPTION COMPLIANCE NOTES/COMMENTS

0 1
1. PREMISES
Medicine Dispensing Area (MDA) (2 marks)
MDA consists of:
 Medicines preparation area (dry and wet
compounding)
 Screening tests area
Signboard and Advertisement (2 marks)
Types of services offered are clearly displayed inside the premise
Photo of the pharmacist(s) on duty is displayed
Facilities (16 marks)
Pharmacist office is available
Waiting area is comfortable with adequate space for customers
Adequate lighting and ventilation
Acceptable noise level
Health Screening Area
 Provide appropriate equipment and devices
 Equipment and devices in are properly maintained
Equipment
a) Computerized system are available with the

45 | P a g e
 Community Pharmacy Benchmarking Guideline 2015

DESCRIPTION COMPLIANCE NOTES/COMMENTS

0 1
following functions:
 Pharmacy Information Software
 Inventory/Stock keeping
 Printing of labels
 Printing of customer information leaflet
 Keeping of patient medication record
 Itemized billing with GST function
 Appropriate drug naming system
b) Printer is available for the production of labels, leaflets or any
printed materials.
Other Requirements
 Entrance is accessible to wheelchairs and
pushchairs.
 Pantry area for staff.
References (1 mark)
Other references e.g:
Malaysian Laws on Poisons and Sale of Drugs
TOTAL (21 marks)

46 | P a g e
 Community Pharmacy Benchmarking Guideline 2015

DESCRIPTION COMPLIANCE NOTES/COMMENTS

0 1
2. PRACTICE AND SERVICES
Services (5 marks)
Optional Services
Medication review and accredited pharmacy services including:
• Home Medication Review (HMR)
• Medication Therapy Adherence Centre (MTAC)
• Certified Smoking Cessation Service Provider (CSCSP)
• Weight management
• Health screening
Personnel (3 marks)
Pharmacy Assistants
 Diploma in Pharmacy (preferred)
 Structured training
 Suitable number
Storage and Security of Medicines (1 mark)
Additional safety control such as video cameras and alarm system
Medication Safety and Quality Improvement Activities (1 mark)
Know Your Medicine activities

47 | P a g e
 Community Pharmacy Benchmarking Guideline 2015

DESCRIPTION COMPLIANCE NOTES/COMMENTS

0 1
TOTAL (10 marks)
3. STANDARD OPERATING PROCEDURE
Self-monitoring Devices (3 marks)
 Pharmacist provides general advice on health matters.
 Pharmacists have undergone appropriate training on the
usage of self-monitoring devices.
 Patients are encouraged to document their own results
(help them to understand the results).
Health Screening (6 marks)
 All staffs involved in providing the above service are
trained in the use of the monitoring devices and the
procedures. They also are aware of the limits of the tests
provided.
 Suitable area with facilities to perform the tests and
provide counseling is available.
 Devices used are in good order.
 Keep up to date with the latest development and know
when to refer patients to medical practitioners.

48 | P a g e
 Community Pharmacy Benchmarking Guideline 2015

DESCRIPTION COMPLIANCE NOTES/COMMENTS

0 1

 The related procedure has been explained to the patient

before test is conducted.
 Test results are communicated to the patient in a manner
in which he/she can understand and appropriate
counseling is provided.
TOTAL (9 marks)

49 | P a g e
 Community Pharmacy Benchmarking Guideline 2015

SECTION 3: COMPULSORY
(if service/product(s) available)

50 | P a g e
 Community Pharmacy Benchmarking Guideline 2015

DESCRIPTION COMPLIANCE COMMENTS

0 1
1. PREMISES
Facilities (6 marks)
A washbasin with water supply is available in the medicines
preparation area
“Wet Compounding Area”
(for the purpose of extemporaneous preparations only)
 A designated area with sink and water supply.
 Located away from food and drinks.
 All working surfaces are made of smooth impervious
surface and washable material finishing.
 Equipped with the following (if applicable):
i. Weighing scale – with regular verification and
calibration by relevant bodies
ii. Mortar and pestle, tile/glass slabs with spatula and
measuring appliances – all are maintained in good
condition

TOTAL (6 marks)

51 | P a g e
 Community Pharmacy Benchmarking Guideline 2015

DESCRIPTION COMPLIANCE COMMENTS

0 1
2. PRACTICE AND SERVICES
Storage and Security of Medicines (2 marks)
Psychotropic drugs are kept according to Regulations 24, Poison
(Psychotropic Substances) Regulations 1989.
Dangerous Drugs are kept according to Regulations 9(2) Dangerous
Drugs Regulations 1952.
TOTAL (2 marks)
3. STANDARD OPERATING PROCEDURE
Extemporaneous Dispensing (8 marks)
 Formula and method of preparation are correct.
 Requisite facilities and equipment for the preparation are
available and maintained in good order.
 Ingredients are sourced from reliable pharmaceutical
supplier and be of a quality accepted for use in the
preparation of the extemporaneous products.
 All calculations, ingredients and quantities are checked by a
second person who is a pharmacist.
 Pharmacists paid particular attention to substances that
may be hazardous and require special handling techniques.

52 | P a g e
 Community Pharmacy Benchmarking Guideline 2015

DESCRIPTION COMPLIANCE COMMENTS

0 1

 The products are suitably labeled with the necessary

information, including special requirements for the safe
handling and storage of the product including an expiry
date.
 All preparations are documented and the records are kept
for at least 2 years. The records included the formula, the
ingredients and the quantities used their source, batch
number, expiry date, date of preparation and personnel
involved in the preparation.
 All documentations are certified and duly stamped by a
registered pharmacist with his/her registration number
indicated.
TOTAL (8 marks)

53 | P a g e
 Community Pharmacy Benchmarking Guideline 2015

AUDIT DESCRIPTION

NO AUDIT COMPONENTS MARKS

Full Marks Obtained Marks Percentage (%)

SECTION 1 (Compulsory)
1. Ownership 1
2. Premises 28
3. Practice and Services 33 / 80
4. Standard Operating Procedures 8
TOTAL 70
SECTION 2 (Optional)
1. Premises 21
2. Practice and Services 10 / 20
3. Standard Operating Procedures 9
TOTAL 40
GRAND TOTAL

SECTION 3 (Compulsory if service/product(s) available)

1. Premises 6
2. Practice and Services 2
3. Standard Operating Procedures 8
TOTAL 16

54 | P a g e
 Community Pharmacy Benchmarking Guideline 2015

AUDIT DESCRIPTION

NO AUDIT COMPONENTS COMMENT / OBSERVATION STATUS

(O/R)

1. SECTION 1
 Ownership
 Premises
 Practice and Services
 Standard Operating
Procedures
2. SECTION 2
 Premises
 Practice and Services
 Standard Operating
Procedures
3. SECTION 3
 Premises
 Practice and Services
 Standard Operating
Procedures
Note: O : Observation
R : Remedial Action Required
55 | P a g e
 Community Pharmacy Benchmarking Guideline 2015

Auditor’s Comment

Remedial Action/s Required

56 | P a g e
 Community Pharmacy Benchmarking Guideline 2015

CONFIDENTIAL

PHARMACY BOARD OF MALAYSIA SUMMARY OF COMMUNITY PHARMACY BENCHMARKING REF. NO:

AUDIT
Community Pharmacy: Address:

Recommended
Recommended after remedial action taken
Re-audit

Reported by : Verified by:

Name : _______________________________ Name : _______________________________

Signature : _______________________________ Signature : _______________________________

Date : _______________________________ Date : _______________________________

 Community Pharmacy Benchmarking Guideline 2015

PHARMACY BOARD OF MALAYSIA

Ministry of Health

Lot 36, JalanUniversiti,

46350 Petaling Jaya, Selangor

Tel : 03-7841 3200

Faks : 03-7841 3658